ArticleArchives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists2025
Normative Data for the Famous People Fluency Test in the Adult French-Quebec Population and Validation Study in Mild Cognitive Impairment and Alzheimer's Disease.
Article in Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The MINT Sprint 2.0: a Picture Naming Test for Detection of Naming Impairments in ΜCI Due or Not to AD, Greek Version.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2026Article
- Quebec French Version of the Hayling Sentence Completion Test: Error Scoring Guidelines, Normative Data for Adults and the Elderly and Validation Study in Mild Cognitive Impairment and Alzheimer's Disease.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2025Article
- Mini-SEA: Validity and Normative Data for the French-Quebec Population Aged 50 Years and Above.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
objectiveThe production of words in verbal fluency tests relies heavily on executive functions and linguistic abilities. New tests such as the famous people fluency test can also be useful in clinical practice and research. This test, in which participants are asked to name so many famous people, has the potential to distinguish healthy individuals from participants with neurological disorders such as mild cognitive impairment or Alzheimer's disease.
methodThe aim of this study was to determine the psychometric validity of the test (Study 1) and to provide normative data in the adult population of French Quebec for the famous people fluency test (Study 2).
resultsThe results of the normative study, derived from a sample of 378 healthy individuals between the ages of 50 and 92, showed that age and educational level significantly influence performance on the test. Therefore, percentile ranks were calculated for performance on the famous people fluency test, stratified for these two variables. The results of Study 2 showed that the test differentiated the performance of healthy participants from the performance of participants with mild cognitive impairment or Alzheimer's disease. The results also showed that the famous people fluency test has adequate convergent validity, established with a semantic fluency test, and that the results showed good stability over time (test-retest validity).
conclusionNorms and psychometric data for the famous people fluency test will improve the ability of clinicians and researchers to better recognize executive and language impairments associated with pathological conditions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.